Dr. Prashant Devrukhakar

Experience

• 

  US Pharmacopeia

  Jul 2009 - Jun 2010

  Project Trainee

  I have successfully accomplish dissertation work titled as ‘Validated Stability Indicating RP-HPLC Assay Method for Combination of Antiviral Drugs’ under the guidance of Dr. K.V. Surendranath, Vice President, USP India Pvt. Ltd., Hyderabad and Dr. Nalini Shastri, Associate Professor, NIPER Hyderabad

• 

  United States Pharmacopeia India Pvt.Ltd

  Apr 2011 - Feb 2016

  Scientist II

  The United States Pharmacopeia (USP) is the official pharmacopeia of the United States, published dually with the National Formulary as the USP-NF. The United States Pharmacopeial Convention (usually also called the USP) is the nonprofit organization that owns the trademark and copyright to the USP-NF and publishes it every year. USP establishes written (documentary) and physical (reference) standards for medicines, food ingredients, dietary supplement products and ingredients. These standards are used by regulatory agencies and manufacturers to help to ensure that these products are of the appropriate identity, as well as strength, quality, purity, and consistency. Before sending out, we test these standards and it involves various techniques such as Ultra High Pressure Liquid Chromatography (UHPLC), High Performance Liquid Chromatography (HPLC), Differential Scanning Caloriemetry (DSC), Thermo gravimetric analysis (TGA), Inductive coupled plasma – optical emission spectroscopy (ICP-OES), High Performance Thin Layer Chromatography (HPTLC), Ultra-Violet Visible Spectroscopy (UV), Water Content analysis, Titration (Aqueous and Non-aqueous), Elemental analysis (Elementar and Thermo), Melting Range (Optimelt), Loss on Drying (LOD), Residue on Ignition (ROI), Specific Optical Rotation (SOR) and Infrared spectroscopy (IR). We also involved in IQ, OQ and PQ of equipments. We have worked under ISO 9001 and ISO 17025 certified lab. Our posted results were cross checked with other three collaborators. Show less

• 

  Novartis

  Mar 2016 - Jul 2022

  • Expert

    Sept 2021 - Jul 2022

  • Senior Scientist

    Mar 2016 - Sept 2021
• 

  Eli Lilly and Company

  Jul 2022 - now

  Senior Manager